Opportunity

SAM #75N98026Q01157

Procurement of Alamar ARGO HT System for NIH Office of Acquisitions

Buyer

NIH Office of Logistics and Acquisition Operations

Posted

September 08, 2026

Respond By

September 17, 2026

Identifier

75N98026Q01157

NAICS

334516

The National Institutes of Health (NIH) Office of the Director, Office of Acquisitions, is seeking to procure a high-throughput proteomics platform for advanced research applications. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Acquisitions - OEM Highlight: - Alamar is the specified Original Equipment Manufacturer (OEM) - Product Requested: - Alamar ARGO HT System - Fully automated, high-throughput proteomics platform - Capable of processing up to 288 samples per run - Integrated qPCR and NGS workflows - Cartridge-based reagent system - Onboard computing with cloud-based primary and secondary analysis software (ARGO Command Center and NULISA Analysis Software) - Supports ultra-high sensitivity NULISA assay technology - Scalable multiplexing and broad sample compatibility - API for custom method development - Compliance with EMC, UL, CE, WEEE, ISO 13485, ISO 9001 standards - Operating conditions: 15-24°C, 40-80% non-condensing humidity - Electrical: 100-240 V, 50-60 Hz, max 1500 watts - Footprint: ≤1143 mm (W) x 661 mm (D) x 1016 mm (H), ≤250 kg - Quantity: - 1 system - Notable Requirements: - Delivery required within 90 days from award - Set aside for small businesses under NAICS code 334516 - Must meet all specified regulatory and technical requirements

Description

ARGO HT instrument must be able to provide the following features:  

Must provide a fully automated, high-throughput proteomics platform capable of processing up to 288 samples per run Must provide an integrated qPCR system enabling end-to-end workflow from sample preparation to data output or pooled NGS library generation Must provide a total hands-on time of less than 30 minutes with simplified workflow and <5-minute instrument setup Must provide results in <6 hours for singleplex assays and <15 hours for multiplex NGS assays Must provide cartridge-based reagent system capable of supporting up to three consecutive runs without replacement Must provide liquid handling system for automated sample preparation for both qPCR and NGS workflows Must provide integrated onboard computing with intuitive user interface for streamlined operation and workflow management Must provide a built-in cloud-based primary analysis software (ARGO Command Center) and secondary analysis software (NULISA Analysis Software, NAS) Must provide capability to transform raw data into biological insights and publication-ready results through integrated data analysis tools Must provide compatibility with ultra-high sensitivity NULISA™ assay technology enabling attomolar-level detection of protein biomarkers Must provide scalable multiplexing capability supporting singleplex to high-plex (100s–1000s of targets) biomarker analysis Must provide broad sample compatibility including plasma, serum, cerebrospinal fluid (CSF), urine, and cell culture media Must provide an application programming interface (API) available for custom method development and instrument control Must provide compliance with major regulatory and safety standards including EMC, UL, CE, WEEE, ISO 13485, and ISO 9001 Must provide operating conditions supporting 15–24°C temperature range and 40–80% non-condensing humidity Must provide electrical compatibility with 100–240 V power supply, 50–60 Hz, and maximum power consumption of 1500 watts Must provide instrument footprint no larger than 1143 mm (W) × 661 mm (D) × 1016 mm (H) and weight no heavier than 250 kg

Delivery must be within 90 days from award

View original listing